Theranostic role of89Zr/177Lu-labeled aflibercept in triple-negative breast cancer

被引：0
|
作者：
Kang, L. [1 ]
Yang, Q. [1 ]
Chen, Z. [1 ]
Qiu, Y. [1 ]
Huang, W. [1 ]
Song, L. [1 ]
机构：
[1] Peking Univ First Hosp, Beijing, Peoples R China
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-622
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 50 条
  • [1] Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
    Qi Yang
    Zhao Chen
    Yongkang Qiu
    Wenpeng Huang
    Tianyao Wang
    Lele Song
    Xinyao Sun
    Cuicui Li
    Xiaojie Xu
    Lei Kang
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1246 - 1260
  • [2] Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
    Yitian Wu
    Tuo li
    Xianzhong Zhang
    Hongli Jing
    Fang Li
    Li Huo
    EJNMMI Radiopharmacy and Chemistry, 9
  • [3] Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
    Wu, Yitian
    Li, Tuo
    Zhang, Xianzhong
    Jing, Hongli
    Li, Fang
    Huo, Li
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2024, 9 (01)
  • [4] 177Lu-labeled aflibercept for theranostic application in renal cancer models
    Chen, Zhao
    Yang, Qi
    Qiu, Yongkang
    Huang, Wenpeng
    Song, Lele
    Sun, Xinyao
    Kang, Lei
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [5] Enhanced Theranostic Efficacy of 89Zr and 177Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice
    Chen, Zhao
    Yang, Qi
    Song, Lele
    Qiu, Yongkang
    Wang, Tianyao
    Wu, Sitong
    Huang, Wenpeng
    Sun, Xinyao
    Wang, Aixiang
    Kang, Lei
    MOLECULAR PHARMACEUTICS, 2024, 21 (05) : 2544 - 2554
  • [6] 177Lu-labeled aflibercept for theranostic application in renalcancer models
    Kang, L.
    Chen, Z.
    Yang, Q.
    Qiu, Y.
    Huang, W.
    Song, L.
    Sun, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S402 - S402
  • [7] Theranostics of lymphoma with 89Zr- and 177Lu-labeled daratumumab
    Kang, Lei
    Jiang, Dawei
    Ehlerding, Emily
    Ferreira, Carolina
    Yu, Bo
    Barnhart, Todd
    Wang, Rongfu
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [8] CD38-Targeted Theranostics of Lymphoma with 89Zr/177Lu-Labeled Daratumumab
    Kang, Lei
    Li, Cuicui
    Rosenkrans, Zachary T.
    Huo, Nan
    Chen, Zhao
    Ehlerding, Emily B.
    Huo, Yan
    Ferreira, Carolina A.
    Barnhart, Todd E.
    Engle, Jonathan W.
    Wang, Rongfu
    Jiang, Dawei
    Xu, Xiaojie
    Cai, Weibo
    ADVANCED SCIENCE, 2021, 8 (10)
  • [9] 64Cu/177Lu-DOTA-diZD, a Small-Molecule-Based Theranostic Pair for Triple-Negative Breast Cancer
    Huang, Yuqian
    Yang, Zhen
    Li, Feng
    Zhao, Hong
    Li, Chun
    Yu, Nam
    Hamilton, Dale J.
    Li, Zheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (05) : 2705 - 2713
  • [10] A preclinical evaluation of 89Zr-labeled PSMA ligands for pre-treatment dosimetry for 177Lu-labeled PSMA therapy
    Prive, B.
    Derks, Y. H. W.
    Franssen, G. M.
    Peters, S. M. B.
    Konijnenberg, M. W.
    Gotthardt, M.
    Janssen, M. J. R.
    Laverman, P.
    Nagarajah, J.
    Heskamp, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S374 - S375
12345